https://www.zacks.com/stock/news/2242230/new-strong-sell-stocks-for-march-18th?cid=CS-ZC-FT-tale_of_the_tape|new_zacks_5_rank_stocks-2242230
Mar 18, 2024 - ACNB, AMPH and TRDA have been added to the Zacks Rank #5 (Strong Sell) List on March 18, 2024.
zc:-4080570614994921898
0
https://www.zacks.com/commentary/2215536/3-generic-drug-stocks-to-watch-amid-improving-market-prospects?cid=CS-ZC-FT-industry_outlook-2215536
Jan 25, 2024 - With the ease in inflationary pressure, the Zacks Medical - Generic Drugs industry is expected to benefit from declining costs. New product launches provide some respite to AMPH, RDY and TEVA.
zc:315080323919066931
0
https://www.zacks.com/stock/news/2212996/centene-cnc-chosen-to-serve-new-hampshire-s-medicaid-members?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2212996
Jan 19, 2024 - Centene's (CNC) subsidiary has been selected by the DHHS to serve the diversified health needs of members of New Hampshire's Medicaid program and thereby, earn more members.
zc:5961121629571381440
0
https://www.zacks.com/stock/news/2209962/snap-these-4-top-ranked-liquid-stocks-to-drive-solid-returns?cid=CS-ZC-FT-analyst_blog|rw-2209962
Jan 15, 2024 - Here are four top-performing liquid stocks, American Public Education (APEI), Amphastar Pharmaceuticals (AMPH), GigaCloud (GCT) and Oceaneering International (OII), which investors can add to their portfolio to boost returns.
zc:-2497691600806730364
0
https://www.zacks.com/stock/news/2204183/amphastar-pharmaceuticals-amph-is-up-1-53-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2204183
Jan 01, 2024 - Does Amphastar Pharmaceuticals (AMPH) have what it takes to be a top stock pick for momentum investors? Let's find out.
zc:-1238513084179144667
0
https://www.zacks.com/stock/news/2203857/here-s-why-you-should-retain-centene-cnc-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2203857
Dec 29, 2023 - Centene (CNC) remains well-poised for growth on the back of overall membership growth, acquisitions, business streamlining efforts and a growing cash balance.
zc:-7654518612008347035
0
https://www.zacks.com/stock/news/2202634/are-medical-stocks-lagging-arch-therapeutics-arth-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2202634
Dec 27, 2023 - Here is how Arch Therapeutics, Inc. (ARTH) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.
zc:-973641090518453135
0
https://www.zacks.com/stock/news/2202621/wall-street-analysts-think-amphastar-amph-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2202621
Dec 27, 2023 - According to the average brokerage recommendation (ABR), one should invest in Amphastar (AMPH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
zc:2884225912877856808
0
https://www.zacks.com/stock/news/2202102/5-good-opportunities-on-relative-price-strength-strategy?cid=CS-ZC-FT-analyst_blog|rw-2202102
Dec 26, 2023 - AMPH, FOUR, BECN, HOFT and HTH are five stocks with explosive relative price strength.
zc:1561104593418485592
0
https://www.zacks.com/stock/news/2196609/what-s-in-store-for-nasdaq-in-2024-5-top-picks?cid=CS-ZC-FT-analyst_blog|investment_ideas-2196609
Dec 12, 2023 - After a strong 2023, we expect the Nasdaq to log gains in 2024. Top-ranked Nasdaq stocks GigaCloud Technology Inc (GCT), Carrols Restaurant Group (TAST), Limbach (LMB), Amphastar Pharmaceuticals (AMPH) and Insight Enterprises Inc (NSIT) could emerge as winning picks.
zc:333035159135204137
0